Market Research Reports- Consulting Analysis Crystal Market Research Pen Needle Market | Seite 2

rise in geriatric population, and standard pen needles being cost effective as compared to other insulin
delivery methods. However, standard pen needles are expected to witness decline in the growth during
forecast period due to various risks of needle related injuries such as rupture of blood vessel while
injecting insulin in the body. Among various needles available, 8mm needle length accounted for the
largest share of the global market in 2016; as these needles are prescribe to large number of people
including obese people. Insulin therapy segment dominated the overall market in 2016, primarily due to
increasing adoption of self-administration of insulin for diabetes type-1 as well as type-2. With increasing
trend in e-commerce, online purchase segment will witness high growth during the forecast period.
Europe accounted for the major share of the global pen needles market in 2016, primarily due to rising
diabetic population, increased funding for diabetic research, high adoption of technologically advanced
devices, and rise in demand for safe insulin delivery methods. However, Asia-Pacific is expected to
witness high growth in forecast period, due to increasing demand for better healthcare infrastructure and
rise in awareness about commercially available treatments for diabetes.
Request a sample copy of Pen Needle Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0515
Major players in the market are Becton, Dickinson and Company, Novo Nordisk A/S, Owen Mumford,
Ltd., HTL-STREFA S.A., B. Braun Melsungen, Ypsomed Holding AG, Terumo Corporation, and Allison
Medical, Inc. These players are highly focused on developing advanced products for the treatment of
diabetes. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm pen
needle with easy flow technology for easier and faster delivery of insulin in the body. Advanced features
such as easy flow with 5mm needles and digitalized pen needles will dominate the market in coming
years.
Key Findings of the Research Study:





Standard pen needles segment accounted for the largest share of the global market in 2016, due to
increase in diabetic population and availability of cost effective standard pen needles.
Reusable and disposable pen needles segment accounted for almost equal share with reusable
having slightly higher market share in 2016.
U.S. dominated the global market and will continue to dominate during forecast period due to
high demand for technologically advanced devices and availability of better health infrastructure.
4mm needle length segment is expected to witness highest growth rate during forecast period due
to its short length.
Insulin therapy segment dominated the global market in 2016, owing to increasedpreferencefor
self-administration of insulin.